We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+5.62%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$16.5B
AUM Growth
+$861M
Cap. Flow
+$217M
Cap. Flow %
1.32%
Top 10 Hldgs %
30.08%
Holding
735
New
44
Increased
335
Reduced
212
Closed
49

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$60.1M
2
QCOM icon
Qualcomm
QCOM
+$53.4M
3
NU icon
Nu Holdings
NU
+$48.5M
4
AMZN icon
Amazon
AMZN
+$46.5M
5
BMA icon
Banco Macro
BMA
+$43.2M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$40.8M
2
ADBE icon
Adobe
ADBE
+$36.1M
3
VIPS icon
Vipshop
VIPS
+$33.1M
4
SBUX icon
Starbucks
SBUX
+$31.4M
5
LOW icon
Lowe's Companies
LOW
+$29.1M

Sector Composition

Rank Sector Weight
1 Technology 33%
2 Healthcare 27.47%
3 Financials 9.69%
4 Consumer Discretionary 7.72%
5 Industrials 6.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEE icon
76
NextEra Energy
NEE
$187B
$47.2M 0.29%
666,673
-18,112
-3% -$1.29M
AWK icon
77
American Water Works
AWK
$26.3B
$46.7M 0.28%
361,674
+10,284
+3% +$1.3M
BNTX icon
78
BioNTech
BNTX
$22.6B
$46.5M 0.28%
578,998
+418,695
+261% +$38.3M
ROK icon
79
Rockwell Automation
ROK
$51.4B
$46.4M 0.28%
168,595
-4,164
-2% -$1.12M
IONS icon
80
Ionis Pharmaceuticals
IONS
$9.35B
$45.2M 0.27%
948,266
+36,369
+4% +$1.49M
BMA icon
81
Banco Macro
BMA
$5.7B
$43.2M 0.26%
+754,200
New +$43.2M
BMRN icon
82
BioMarin Pharmaceuticals
BMRN
$11.5B
$43.2M 0.26%
525,138
+146,827
+39% +$12.2M
MDLZ icon
83
Mondelez International
MDLZ
$77.7B
$42.7M 0.26%
651,866
+114,578
+21% +$7.86M
DIS icon
84
Walt Disney
DIS
$165B
$42.2M 0.26%
425,541
-53,670
-11% -$5.78M
OLED icon
85
Universal Display
OLED
$3.71B
$42M 0.25%
199,767
+539
+0.3% +$94.8K
KEYS icon
86
Keysight
KEYS
$54.5B
$41.7M 0.25%
304,781
+6,278
+2% +$917K
ED icon
87
Consolidated Edison
ED
$41.6B
$41.6M 0.25%
465,526
-193,382
-29% -$17.9M
XYL icon
88
Xylem
XYL
$28.5B
$41.3M 0.25%
304,162
+28,999
+11% +$3.95M
JNJ icon
89
Johnson & Johnson
JNJ
$635B
$41M 0.25%
280,235
+6,736
+2% +$1M
ADP icon
90
Automatic Data Processing
ADP
$100B
$40.6M 0.25%
170,117
+16,688
+11% +$4.1M
ABBV icon
91
AbbVie
ABBV
$458B
$39.9M 0.24%
232,481
-12,005
-5% -$1.99M
AMP icon
92
Ameriprise Financial
AMP
$46.8B
$38.8M 0.24%
90,880
+10,942
+14% +$4.67M
BZ icon
93
Kanzhun
BZ
$6.89B
$38.7M 0.23%
2,059,000
+1,292,000
+168% +$26M
MS icon
94
Morgan Stanley
MS
$337B
$38.3M 0.23%
393,841
+210,226
+114% +$20M
SNPS icon
95
Synopsys
SNPS
$71.5B
$37.7M 0.23%
63,398
-1,482
-2% -$838K
ABT icon
96
Abbott
ABT
$180B
$37.4M 0.23%
359,676
+56,167
+19% +$5.96M
INSM icon
97
Insmed
INSM
$23.2B
$37.2M 0.23%
555,934
+165,734
+42% +$6.43M
SLB icon
98
SLB Ltd
SLB
$77.8B
$36.8M 0.22%
779,102
+36,134
+5% +$1.74M
INTU icon
99
Intuit
INTU
$81.1B
$36M 0.22%
54,831
-816
-1% -$506K
ADBE icon
100
Adobe
ADBE
$89.5B
$35.8M 0.22%
64,379
-74,550
-54% -$36.1M

Similar funds

Candriam SCA's Q2 2024 Portfolio in Review

As of Q2 2024, Candriam SCA held 735 positions worth $16.5B, up 5.5% from $15.6B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Candriam SCA's Q2 2024 filing shows 44 new, 335 increased, 212 reduced and 49 closed positions. Its largest new stake was Banco Macro: 754,200 shares worth $43.2M. The largest sale was Apple, an estimated $40.8M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q2 2024 buy was Banco Macro: 754,200 shares worth $43.2M.
  • Candriam SCA added most to Eli Lilly in Q2 2024, an estimated $60.1M increase.
  • Candriam SCA's biggest Q2 2024 reduction was Apple, cutting an estimated $40.8M.
  • Candriam SCA fully exited Alpine Immune Sciences Inc in Q2 2024, selling an estimated $16.5M.
  • Candriam SCA's ten largest holdings make up 30% of its $16.5B portfolio in Q2 2024.
  • Candriam SCA opened 44 new positions and closed 49 in Q2 2024.
  • Candriam SCA's portfolio value rose 5.5% quarter-over-quarter to $16.5B.

Based on Candriam SCA's 13F filing for Q2 2024, filed 5 Aug 2024.